Zobrazeno 1 - 6
of 6
pro vyhledávání: '"I. K. Asherova"'
Autor:
Ye. L. Amelina, I. K. Asherova, I. K. Volkov, Т. Ye. Gembitskaya, Ye. K. Ginter, N. А. Il’yenkova, N. I. Kapranov, I. P. Karimova, N. Yu. Kashirskaya, Ye. I. Kondrat’yeva, М. N. Kostyleva, S. А. Krasovsky, N. B. Merzlova, L. P. Nazarenko, L. S. Namazova-Baranova, А. F. Neretina, V. S. Nikonova, А. V. Orlov, S. S. Postnikov, Т. А. Protasova, S. Yu. Semykin, D. F. Sergienko, О. I. Simonova, I. D. Uspenskaya, М. Yu. Chernukha, L. А. Shabalova, I. А. Shaginyan, V. D. Sherman
Publikováno v:
Вопросы современной педиатрии, Vol 13, Iss 6, Pp 89-95 (2014)
The pulmonary drug administration for the treatment of a pulmonary affection in cystic fibrosis is highly effective. This consensus document summarizes data on inhalation intake of bronchodilators, mucolytics, anti-inflammatory drugs, including gluco
Externí odkaz:
https://doaj.org/article/6524667aa0ed4fb08cf3767cd4dcf923
Publikováno v:
Педиатрическая фармакология, Vol 10, Iss 6, Pp 53-60 (2013)
The article is dedicated to historical and modern trials in the sphere of mucoviscidosis in Russia, peculiarities of clinical manifestations, pathophysiological and pathomorphological disorders and of the disease course with the analysis of the first
Externí odkaz:
https://doaj.org/article/30ce49665a1b4b69bd1971897f163601
Autor:
I. K. Asherova, N. I. Kapranov
Publikováno v:
Педиатрическая фармакология, Vol 9, Iss 3, Pp 96-101 (2012)
The creation of a register of mucoviscidosis (MV) patients is necessary for determining the epidemic situation in the region, evaluating the efficacy of therapeutic strategies and the quality of healthcare provided. The regional register of Yaroslavl
Externí odkaz:
https://doaj.org/article/7ea14b7a146b448ea02672283c80e234
Autor:
O. P. Uhanova, L. S. Kozyreva, S. V. Trishina, T. A. Stepanenko, S. Krasovskiy, N. Ponomareva, G. N. Seitova, L. M. Kudelya, E. L. Amelina, D. I. Abdulganieva, N. P. Revel-Muroz, O. V. Magnitskaya, I. E. Zilber, I. K. Asherova, T. G. Fadeeva, E. M. Reutskaya
Publikováno v:
Russian Pulmonology. 29:695-706
The article discusses the results of a phase III clinical trial to compare the pharmacokinetics, efficacy and safety of the biosimilar medicinal product Tigerase® (dornase alpha) (Generium JSC, Russia) and the reference medicinal product Pulmozyme®
Publikováno v:
Vestnik otorinolaringologii. (1)
A clinical trial was made of two types of laryngeal endoprostheses in surgery of stenosis caused by benign diseases. A total of 15 patients were operated on. In 11 patients endoprosthesis of biocompatible polymers was inserted, in 4 patients the sten
Publikováno v:
Vestnik otorinolaringologii. (5)